Northwest Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Northwest Capital Management's NVS Position: Q3 2025 in Review
Northwest Capital Management sold out of Novartis (NVS) in Q3 2025, closing a stake of 5,000 shares — an estimated $605K sold.
Northwest Capital Management first reported a position in NVS in Q3 2018 and held it in 28 quarters. The position peaked at $605K in Q2 2025. 1,401 funds tracked by Wall St. Rank hold NVS as of Q3 2025.
- Northwest Capital Management reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
- Northwest Capital Management sold 5,000 Novartis shares in Q3 2025, an estimated $605K.
- Northwest Capital Management first reported a position in Novartis in Q3 2018 and held it in 28 quarters.
- Northwest Capital Management's Novartis position peaked at $605K in Q2 2025.
- 1,401 funds tracked by Wall St. Rank held Novartis as of Q3 2025.
Based on Northwest Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.